Inovio Faces Securities Fraud Class Action Over Manufacturing Claims and FDA Setbacks
Pomerantz Law Firm files class action against $INO for alleged securities fraud involving false manufacturing capability and FDA approval claims for INO-3107.
INOsecurities fraudclass action lawsuit